Dr Lalchandani Labs Rights Issue 2026 Details, Record Date, Issue Price

Dr Lalchandani Labs Rights Issue details are now available. The firm plans to issue 43,32,000 equity shares amounting to Rs 4.33 crores. Dr Lalchandani Labs Rights issue price is Rs 10 per share, and the face value is Rs 10 per share.

Dr Lalchandani Labs Rights Issue open date is February 4, 2026 and the close date is February 20, 2026. Dr Lalchandani Labs rights issue entitlement ratio is 1:1, which is 1 Rights Equity Shares for every 1 fully paid-up Equity Shares held on the record date.

Dr Lalchandani Labs Rights Issue record date is January 27, 2026. The last date to buy shares of Dr Lalchandani Labs is January 23, 2026. This rights Issue subscription status will be available soon.

Dr Lalchandani Labs Rights Issue allotment date February 23, 2026, credit date is February 24, 2026 and the listing date is February 25, 2026. However, the listing will be on the BSE.

Dr Lalchandani Labs Limited's rights issue registrar is Cameo Corporate Services Ltd. and the book-running lead manager(s) for this rights issue will be available soon.

Also Read | Travels & Rentals Rights Issue 2026 Details, Record Date, Issue Price

Dr Lalchandani Labs Rights Issue Details

Dr Lalchandani Labs Rights Issue details are as follows: the company plans to issue 43,32,000 equity shares, aggregating the amount of Rs 4.33 crores. Dr Lalchandani Labs Rights issue price is Rs 10 per share. The rights issue entitlement ratio is 1:1, which is 1 Rights Equity Shares for every 1 fully paid-up equity share(s).

Dr Lalchandani Labs Rights Issue Dates

Dr Lalchandani Labs Rights issue record date is January 27, 2026 and the last date to buy shares of Dr Lalchandani Labs is January 23, 2026.

Dr Lalchandani Labs Rights Issue Subscription

Dr Lalchandani Labs Rights Issue subscription status will be available after the issue goes live. The details of the Rights Issue entitlement are 1 Rights Equity Share(s) for every 1 fully paid-up Equity Share(s) held on the Record Date. Dr Lalchandani Labs issue price is Rs 10 per share.

Dr Lalchandani Labs Limited: About the Company

Dr Lalchandani Labs Limited stands as a trusted name in diagnostic services across Delhi/NCR, tracing its roots back to 1986 when it began as a pathology lab in Greater Kailash, New Delhi. Founded by Dr. Arjan Lal Chandani, the firm evolved from a proprietorship into Dr. A Lalchandani Pathology Laboratories as a partnership in 2011, before becoming a limited company in 2017. With five NABL-accredited labs and 15 collection centers, it handles everything from biochemistry and hematology tests to advanced molecular pathology, virology, and genetic testing using equipment from Siemens and GE.

The lab processes up to 1000 samples hourly with same-day reports, offering home collection, X-rays, ultrasounds, doctor consultations, corporate health checkups, and hospital lab management. Empaneled with CGHS, DJB, MCD, and DDA, it ensures reliable, hygienic services that patients and doctors count on daily. Customers praise the clean facilities, friendly staff, and accurate results that save time and build confidence in health monitoring.

Dr Lalchandani Labs Limited Financials (Amount in Rs crore)

Dr Lalchandani Labs Rights Issue Registrar

Dr Lalchandani Labs rights issue registrar is Cameo Corporate Services Ltd. and the book-running lead manager(s) for this rights issue will be available soon.

FAQs

1. What are the details of the Dr Lalchandani Labs Rights Issue?

Dr Lalchandani Labs Rights Issue details are as follows: Dr Lalchandani Labs plans to issue 43,32,000 equity shares amounting to Rs 4.33 crores. Dr Lalchandani Labs Rights issue price is Rs 10 per share, and the face value is Rs 10 per share. The rights issue entitlement ratio is 1:1, which is 1 Rights Equity Share(s) for every 1 fully paid-up equity share(s).

2. Dr Lalchandani Labs Rights Issue open date and close date?

Dr Lalchandani Labs Rights Issue's open date is February 4, 2026, and the closing date is February 20, 2026. Dr Lalchandani Labs Rights Issue record date is January 27, 2026. The last date to buy shares of Dr Lalchandani Labs is January 23, 2026.

3. How can I apply for the Dr Lalchandani Labs Rights Issue?

You can apply for Dr Lalchandani Labs in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Dr Lalchandani Labs Rights Issue?

Dr Lalchandani Labs rights issue entitlement ratio is 1:1, which is 1 Rights Equity Share(s) for every 1 fully paid-up equity share(s).

5. How can I check the Dr Lalchandani Labs Issue Allotment Status?

The registrar for the Dr Lalchandani Labs rights Issue is Cameo Corporate Services Ltd. Investors can check the allotment status by visiting the registrar's website.

6. From where can I get the Dr Lalchandani Labs Rights issue Letter of Offer?

You can download the Dr Lalchandani Labs Rights Issue Letter of Offer by visiting here.

7. What is the listing date of the Dr Lalchandani Labs Rights Issue?

The Dr Lalchandani Labs Rights Issue listing date will be available soon. However, the listing will be on the BSE.

8. Who are the registrar and lead managers of the Dr Lalchandani Labs Rights Issue?

Dr Lalchandani Labs rights issue registrar is Cameo Corporate Services Ltd. and the book-running lead manager(s) for this rights issue will be available soon.

Also Read | Galaxy Agrico Exports Rights Issue 2026 Details, Record Date, Issue Price